A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma

Cancer Research

Volumn 60, Issue 4, 2000, Pages 793-798

  Trinei, Mirella ^a   Lanfrancone, Luisa ^a   Campo, Elias ^b   Pulford, Karen ^c   Mason, David Y ^c   Pelicci, Pier Giuseppe ^a   Falini, Brunangelo ^d  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; NUCLEOPLASMIN; PROTEIN TYROSINE KINASE;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; LARGE CELL LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS;

3T3 CELLS; ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; HUMANS; LYMPHOMA, LARGE-CELL; MALE; MICE; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; NUCLEOTIDE DEAMINASES; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS;

EID: 0034652639     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Morris, S. W., Naeve, C., Mathew, P., Kirstein, M. N., Cui, X., and Witte, D. P. ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural-specific receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene, 14: 2175-2188, 1997.
2. Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., and Yamamoto, T. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene, 14: 439-449, 1997.
3. Benharroch, D., Meguerian-Bedoyan, Z., Lamant, L., Amin, C., Brugieres, L., Terrier-Lacombe, M. J., Haralambieva, E., Pulford, K., Pileri, S., Morris, S., Mason, D. Y., and Delsol, G. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood, 91: 2076-2084, 1998.
4. Falini, B., Bigerna, B., Fizzotti, M., Pulford, K., Pileri, S. A., Delsol, G., Carbone, A., Paulli, M., Magrini, U., Menestrina, F., Giardini, R., Pilotti, S., Mezzelani, A., Ugolini, B., Billi, M., Pucciarini, A., Pacini, R., Pelicci, P. G., and Flenghi, L. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am. J. Pathol., 153: 875-886, 1998.
5. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R., and Lennert, K. The expression of Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissues: evidence that Sternberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66: 848-858, 1985.
6. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P., Chan, J. K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H. K., Pileri, S. A., Ralfkier, E., and Warnke, R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84: 1361-1392, 1994.
7. Falini, B., Pileri, S., Pizzolo, G., Durkop, H., Flenghi, L., Stirpe, F., Martelli, M. F., and Stein, H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood, 85: 1-14, 1995.
8. Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J., Plantier, I., Berger, F., Symann, M., Petrella, T., Lederlin, P., and Briere, J. for the Groupe d'Etudes des Lymphomes de l'Adulte. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90: 3727-3734, 1997.
9. Kadin, M. E. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv., 30: 77, 1997.
10. Mason, D. Y., Bastard, C., Rimokh, R., Dastugue, N., Huret, J. L., Kristoffersson, U., Magaud, J. P., Nezelof, C., Tilly, H., Vannier, J. P., Hemet, J., and Warnke, R. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br. J. Haematol., 74: 161, 1990.
11. Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (Washington DC), 263: 1281-1284, 1994.
12. Ladanyi, M. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv., 30: 59-75, 1997.
13. Shiota, M., Fujimoto, J., Semba, T., Satoh, H., Yamamoto, T., and Mori, S. Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene, 9: 1567-1574, 1994.
14. Borer, R. A., Lehner, C. F., Eppenberger, H. M., and Nigg, E. A. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell, 56: 379-390, 1989.
15. Bischof, D., Pulford, K., Mason, D. Y., and Morris, S. W. Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic kinase fusion protein in oncogenesis. Mol. Cell. Biol., 17: 2312-2325, 1997.
16. Pulford, K., Falini, B., Cordell, J., Rosenwald, A , Ott, G., Müller-Hermelink, H. K., MacLennan, K. A., Delsol, G., Campo, E., and Mason, D. Y. Biochemical detection of novel ALK proteins in tissue sections of anaplastic large cell lymphoma. Am. J. Pathol., 154: 1657-1663, 1999.
17. Rosenwald, A., Ott, G., Pulford, K., Katzenberger, T., Kühl, J., Kalla, J., Ott, M. M., Mason, D. Y., and Müller-Hermelink, H. K. t(1;2) (q21;p23) and t(2;3) (p23;q21): two novel variant translocations of the t(2;5) (p23;q35) in anaplastic large cell lymphoma. Blood, 94: 362-364, 1999.
18. Wlodarska, I., De Wolf-Peeters, C., Falini, B., Verhoef, G., Morris, S. W., Hagemeijer, A., and Van den Berghe, H. The cryptic inv(2) (p23q35) defines a new molecular genetic subtype of ALK-positive ALCL. Blood, 92: 2688-2695, 1998.
19. Pulford, K., Lamant, L., Morris, S., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G., and Mason, D. Y. Detection of ALK and NPM-ALK protein in normal and neoplastic cells with the monoclonal antibody ALK1. Blood, 89: 1394-1404, 1997.
20. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., and Mariame, B. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2) (q25;p23) translocation. Blood, 93: 3088-3095, 1999.
21. Hernandez, L., Pinyol, M., Hernandez, S., Bea, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., Delsol, G., and Campo, E. TRK-fused gene (TFG) is a new partner of ALK in anapalstic large cell lymphoma producing two structurally different TFG-ALK translocations. Blood, 94: 3265-3268.
22. Cordell, J., Pulford, K., Bigerna, B., Roncador, G., Banham, A., Colombo, E., Pelicci, P. G., Mason, D. Y., and Falini, B. Detection of normal and chimeric nucleophosmin in human cells. Blood, 93: 632-642, 1999.
23. Chenchik, A., Moqadam, F., and Siebert, P. A new method for full-length cDNA cloning by PCR. In: P. A. Krieg (ed.), A Laboratory Guide to RNA: Isolation, Analysis, and Synthesis, pp. 273-321. New York: Wiley-Liss, Inc., 1996.
24. Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Grignani, F., Pawson, T., and Pelicci, P. G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal. Cell, 70: 93-104, 1992.
25. Falini, B., Pulford, K., Pucciarini, A., Carbone, A., De Wolf-Peeters, C., Cordell, J., Fizzotti, M., Santucci, A., Pelicci, P. G., Pileri, S., Campo, E., Ott, G., Delsol, G., and Mason, D. Y. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood, 94: 3509-3515, 1999.
26. Sugita, T., Aya, H., Ueno, M., Ishizuka, T., and Kawashima, K. Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase. J. Biochem., 122: 309-313, 1997.
27. Rayl, E. A., Moroson, B. A., and Beardsley, P. The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formytransferase/IMP cyclohydrolase. J. Biol. Chem., 271: 2225-2233, 1996.
28. Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., and Yamamoto, T. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA, 93: 4181-4186, 1996.
29. Bai, R., Dieter, P., Peschel, C., Morris, S. W., and Duyster, J. Nucleophosminanaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-γ to mediate its mitogenicity. Mol. Cell. Biol., 18: 6951-6961, 1998.
30. Beardsley, G. P., Rayl, E. A., Gunn, K., Moroson, B. A., Seow, H., Anderson, K. S., Vergis, J., Fleming, K., Worland, S., Condon, B., and Davies, J. Structure and functional relationship in human purH. In: Griesmacher et al. (eds.), Purine and Pyrimidine Metabolism in Man, Ed. 9. New York: Plenum Press, 1998.
31. Beardsley, G. P., Rayl, E. A., Gunn, K., Moroson, B. A., Seow, H., Anderson, K. S., Vergis, J., Fleming, K., Worland, S., Condon, B., and Davies, J. Structure and functional relationships in human purH. Adv. Exp. Med. Biol., 431: 221-226, 1998.
32. Levdikov, V. M., Barynin, V. V., Grebenko, A. L., Melik-Adamyan, W. R., Lamzin, V. S., and Wilson, K. S. The structure of SAICAR synthase: an enzyme in the de novo pathway of purine nucleotide biosynthesis. Structure (Lond.), 15: 363-376, 1998.
33. Allegra, C. J., Drake, J. C., Jolivet, J., and Chabner, B. A. Inhibition of phosphoribosylaminoimidazolecarboxamidetransformilase by methotrexate and dihydrofolic acid polyglutamates. Proc. Natl. Acad. Sci. USA, 82: 4881-4885, 1985.
34. Greco, A., Mariani, C., Miranda, C., Lupas, A., Pagliardini, S., Pomati, M., and Pierotti, M. A. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Mol. Cell. Biol., 15: 6118-6127, 1995.
35. Cote, G. P., and Smillie, L. B. Preparation and some properties of equine platelet tropomyosin. J. Biol. Chem., 256: 11004, 1981.
36. Mason, D. Y., Pulford, K., Bischof, D., Kuefer, M. U., Butler, L. H., Lamant, L., Delsol, G., and Morris, S. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase tyrosine kinase is not required for malignant transformation. Cancer. Res., 58: 1057-1062, 1998.